News
STAT+: Merck suffers a setback in Europe over its new Keytruda formulation
In a setback for Merck, a Dutch court ordered a halt to the manufacturing and marketing of a subcutaneous formulation of Keytruda in several European countries.
More in Health
- She got Trump's $500 check for health insurance. To her, it's a 'political stunt' NPR — Health
- Eleven bail hostels due to house early release prisoners in England and Wales closed The Guardian — Society
- New global guidelines warn against obesity drugs for children under 10 BBC News — Health
- Dying Patients Are Inundated by Misinformation. My Dad Was One of Them. The New York Times — Health
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health World Health Organization